©2020 Reimagined Ventures LLC.
All Rights Reserved.

Learn more about how we are reimagining the world

Portfolio news

D.C. United Valued at more than $800M in Minority Stake Sale

D.C. United is in the final stages of bringing on several new investors in the club and its related businesses at an enterprise value of slightly more than $800M, the highest ever for an MLS team selling a minority stake.

September 28, 2022

Read more
Portfolio news

TAE Exceeds Fusion Reactor Performance Goals by 250% to Reach 75 Million Degrees as Company Closes $250 Million Financing Round

After achieving temperatures greater than 75 million degrees Celsius and demonstrating unmatched real-time control of plasma with its state-of-the-art fusion research reactor, Norman, TAE today announced that it has secured $250M of strategic and institutional investments to fund the construction of its next research reactor, Copernicus.

July 19, 2022

Read more
Portfolio news

Climate Data & Community Solar Start-up Arcadia Rases $200M

Arcadia, the tech company empowering energy innovators to fight the climate crisis, announced it completed its latest $200M Series E financing round, valuing it at an impressive $1.5B! Notably, this round also included the first major investment from J.P. Morgan’s new climate fund, a historic marker as large investment firms continue to recognize the incredible value being created by the next generation of energy transition companies.

May 09, 2022

Read more
Portfolio news

Major Multinational Pharma Company Leads Series B "Extension Round" for ActivSurgical

Hikma Pharmaceuticals, the multinational pharmaceutical company, today announced that its venture capital arm has led a $15M round of financing for Activ Surgical, a pioneering digital surgery imaging startup that is developing groundbreaking interoperative surgical intelligence hardware and software. The investment is an extension of the Series B round that was previously announced by Activ Surgical in September 2021. This most recent financing, which also saw participation from existing investors, brings the total Series B round to $60M.

March 28, 2022

Read more

Innovative HR Platform Bambee Raises $30M in Heavily Oversubscribed Series C Round in February 2022

Bambee, a company that makes Human Resources affordable for small to medium-sized businesses, announced a $30M dollar Series C round in late March, bringing its total funding to $65M. The company grew topline by 100% in 2021 and is on track to double again in 2022.

March 28, 2022

Read more

Leading Digital Fitness & Wellness Company Future Raises $75M in Series C Funding

Future will use the fresh capital, which brings its total funding to more than $110 million, on advertising and to hire more full-time fitness trainers to further increase its status as one of the largest trainer networks in the U.S. Future will also use the capital to expand into new categories as well, including stress management and nutrition.

February 03, 2022

Read more

SRAM, a Global Leader in Bicycle Component Manufacturing, Announces the Acquisition of Leading Cycling Technology Company Hammerhead

SRAM, one of the world’s leading bicycle component manufacturers, announced today the acquisition of Hammerhead, a leading cycling technology company and maker of the Karoo 2 cycling computer. Hammerhead will join SRAM’s portfolio of brands and will continue to develop its Karoo product line under the SRAM portfolio and grow its innovative cycling technology platform.

January 20, 2022

Read more

Leading Bitcoin Firm NYDIG Raises $1B in New Funding From Investors

NYDIG's robust infrastructure platform helps to allow banks, credit unions, and merchants to embed bitcoin services in their websites or smartphone apps. NYDIG plans to use this addition financing round, which included investors like included Morgan Stanley, Mass Mutual, and New York Life Insurance, to further expand their offerings across its trading, brokerage, custody, and asset-management segments.

December 15, 2021

Read more

Pear Therapeutics and Thimble Point Announce Closing of Business Combination to Create Publicly Traded Digital Therapeutics Company

Pear Therapeutics, the leader in developing software-based medicines called "prescription digital therapeutics" (PDTs) will use the new capital to further deploy and commercialize its three FDA-authorized PDTs while also expanding Pear's public and private payer adoption.

December 07, 2021

Read more

Cala Health Raises $77M to Expand Patient Access and Fuel Continued Innovation

The new funding round allows the pioneer and leader of bioelectronic medicine to continue building upon their strong foundation in treating essential tremor and develop new therapies to help more patients living with chronic disease

November 18, 2021

Read more